Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Advances in Cardiovascular Imaging
    • AHA Guidelines and Statements
    • Cardiovascular Images
    • How to Use Imaging
    • Special Reports
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation:
Cardiovascular Imaging

  • My alerts
  • Sign In
  • Join

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Advances in Cardiovascular Imaging
    • AHA Guidelines and Statements
    • Cardiovascular Images
    • How to Use Imaging
    • Special Reports
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Sex Effect in Atrial Fibrillation

Is It All About Atrial Function?

Arthur Labovitz, John Meriwether
Download PDF
https://doi.org/10.1161/CIRCIMAGING.116.005624
Circulation: Cardiovascular Imaging. 2016;9:e005624
Originally published October 11, 2016
Arthur Labovitz
From the Department of Cardiovascular Sciences, Morsani College of Medicine, University of South Florida, Tampa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Meriwether
From the Department of Cardiovascular Sciences, Morsani College of Medicine, University of South Florida, Tampa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
Loading
  • Editorials
  • atrial fibrillation
  • echocardiography
  • left atrium
  • stroke

Over the past 25 years, our knowledge concerning embolic stroke, secondary to atrial fibrillation, has increased exponentially. Although it is well accepted that atrial fibrillation increases the risk of stroke in aggregate in a population ≈5-fold, several risk score models exist to further predict who will benefit from stroke prophylaxis with anticoagulants. The CHADS2 risk score had been the standard in assessing risk in any individual patient with atrial fibrillation for several years. More recently, the CHADS2VASC score has become favored by more recent guidelines as the recommended algorithm to guide oral anticoagulant decisions.1,2 This risk model importantly includes female sex as an important risk factor in stroke secondary to atrial fibrillation. This inclusion of female sex as a risk factor was formed on the basis of multiple studies.

See Article by Yoshida et al

Fang et al studied sex differences in over 13 000 patients3 in the ATRIA study (Anticoagulation and Risk Factors in Atrial Fibrillation). His group found almost double the risk of stroke in women compared with men when off warfarin. In studying over 5000 patients taking part in the Euro Heart Survey, Dagres et al4 also found that women had almost twice the risk of stroke. However, in this study, the risk was highest when female sex was in addition to at least one further traditional risk factor. Since development of the CHA2DS2VASc, a plethora of larger studies have confirmed the importance of sex in risk of cardioembolic stroke in atrial fibrillation. The Swedish Atrial Fibrillation Cohort Study looked at over 180 000 patients and showed a hazard ratio of 1.4 for risk of stroke in atrial fibrillation.5 This was similar to the hazard ratio for vascular disease. Friberg looked at over 100 000 patients with atrial fibrillation and without oral anticoagulant, finding women had a 47% higher risk of stroke. When adjusted for more risk factors in the female group, women still had almost 20% higher risk.6 These studies solidified the placement of sex as a risk factor for stroke.

Furthermore, it has been noted that not only are women at greater risk of stroke but, in fact, seem to be susceptible to more severe strokes than men when they do occur.7 In our own retrospective review of over 200 consecutive patients with atrial fibrillation and acute stroke, we found that female sex was associated with a 2-fold risk of severe disabling or fatal recurrent cardioembolic stroke.8 Likewise, Li et al9 reported that women were at a higher risk of more disabling stroke in the setting of atrial fibrillation. Multiple large population studies have confirmed the increased risk of stroke in women.3–5,10 Studies indicate a prevalence of 20% to 50% higher risk in women than in men.6

So then what accounts for this difference observed in the female patient with atrial fibrillation? Previous hypotheses have suggested hormonal influences, including a potential thrombogenic effect of estrogen, as well increased risk secondary to treatment with hormone replacement therapy, or even more common use of antiplatelet therapy in men because of higher rates of atherosclerotic vascular disease. These theories were refuted after further careful examination of the population studied.

The article by Yoshida et al11 in the current issue of Circulation: Cardiovascular Imaging offers perhaps an alternative mechanism for development of cardioemboli and the increased incidence of stroke in women. The authors examined a group of over 400 subjects to test the effective sex difference of CHADS2VASC associations with left atrial function and anatomy. When men and women were compared, the women were found to have evidence of impaired left atrial function. Furthermore, a significant association between the CHA2DS2VASc risk score and left atrial function as evidenced by left atrial ejection fraction was demonstrated in women only. Likewise, global peak left atrial strain showed a similar association. Despite the shortcomings of this study, such as unmatched demographics, an important hypothesis emerges; that is, women with atrial fibrillation are more likely to have impaired LA function.

It has long been noted that the presence of left atrial spontaneous contrast indicates an increased risk for stroke in patients with atrial fibrillation. In fact, the denser the spontaneous echo contrast, the higher the risk of stroke. Likewise, the presence of decreased left atrial appendage velocity in many reports of <20 cm/s indicates a high risk of subsequent cerebral ischemia in these patients. Previous studies have also indicated the relationship between left atrial size and potential for stroke in the presence of atrial fibrillation. Most of the studies were dominated by a high percentage of male patients, making it difficult to evaluate the effects of sex on these structural and functional risk factors of the left atrium.

Previous studies have in fact demonstrated a relationship between left atrial structure and stroke.12,13 Multiple investigators have reported that factors, including left atrial size and function, as well as left atrial appendage velocities, are clearly associated with the development of spontaneous echo contrast, thrombus, and ultimately stroke.14,15 We use the parameters routinely to assess stroke risk in all patients. However, none of these studies have reported an association with female sex.

The findings demonstrated by Yoshida et al, however, need to be kept in context. The relationship between depressed left atrial function and female sex was with CHADS2VASC stroke risk scoring tool. Future research efforts should be directed toward demonstrating a direct relationship between impaired left atrial function and the incidence of and severity of stroke in women.

Additionally, it is concerning that despite an overwhelming amount of evidence pointing to increased rate of stroke in women and new data showing an increased morbidity because of stroke, it seems that women with atrial fibrillation remain under anticoagulation compared with male counterparts.16–19 The differences were significant at ≈5% less for women across the studies. Impressively, Shantsila et al19 found that just <50% of women with an indication for anticoagulation were prescribed an anticoagulant.

In conclusion, the report by Yoshida provides a mechanism of LA dysfunction to explain worse outcomes in females with atrial fibrillation. Findings such as these will have direct clinical implications. Future studies are needed to confirm these findings.

Disclosures

None.

Footnotes

  • The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

  • © 2016 American Heart Association, Inc.

References

  1. 1.↵
    1. January CT,
    2. Wann LS,
    3. Alpert JS,
    4. Calkins H,
    5. Cigarroa JE,
    6. Cleveland JC Jr.,
    7. Conti JB,
    8. Ellinor PT,
    9. Ezekowitz MD,
    10. Field ME,
    11. Murray KT,
    12. Sacco RL,
    13. Stevenson WG,
    14. Tchou PJ,
    15. Tracy CM,
    16. Yancy CW
    ; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2014;64:e1–e76. doi: 10.1016/j.jacc.2014.03.022.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Kirchhof P,
    2. Benussi S,
    3. Kotecha D,
    4. Ahlsson A,
    5. Atar D,
    6. Casadei B,
    7. Castella M,
    8. Diener HC,
    9. Heidbuchel H,
    10. Hendriks J,
    11. Hindricks G,
    12. Manolis AS,
    13. Oldgren J,
    14. Popescu BA,
    15. Schotten U,
    16. Van Putte B,
    17. Vardas P
    . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016. pii: ehw210. doi: 10.1093/europace/euw295.
  3. 3.↵
    1. Fang MC,
    2. Singer DE,
    3. Chang Y,
    4. Hylek EM,
    5. Henault LE,
    6. Jensvold NG,
    7. Go AS
    . Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Ant icoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005;112:1687–1691. doi: 10.1161/CIRCULATIONAHA.105.553438.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Dagres N,
    2. Nieuwlaat R,
    3. Vardas PE,
    4. Andresen D,
    5. Lévy S,
    6. Cobbe S,
    7. Kremastinos DT,
    8. Breithardt G,
    9. Cokkinos DV,
    10. Crijns HJ
    . Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49:572–577. doi: 10.1016/j.jacc.2006.10.047.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Friberg L,
    2. Rosenqvist M,
    3. Lip GY
    . Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33:1500–1510. doi: 10.1093/eurheartj/ehr488.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Friberg L,
    2. Benson L,
    3. Rosenqvist M,
    4. Lip GY
    . Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ. 2012;344:e3522. doi: 10.1136/bmj.e3522.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Nezu T1,
    2. Hosomi N,
    3. Kondo K,
    4. Aoki S,
    5. Matsumoto M,
    6. Kobayashi S
    ; Japan Standard Stroke Registry Study Group. Greater severity of neurological defects in women admitted with atrial fibrillation-related stroke. Circ J. 2016;80:250–255. doi: 10.1253/circj.CJ-15–0873.
    OpenUrl
  8. 8.↵
    1. Martin RC,
    2. Burgin WS,
    3. Schabath MB,
    4. Kirby B,
    5. Chae SH,
    6. Fradley MG,
    7. Rose DZ,
    8. Labovitz AJ
    . Impact of female gender on disability and death in atrial fibrillation related stroke. Am J Cardiol. In press.
  9. 9.↵
    1. Li S,
    2. Zhao X,
    3. Wang C,
    4. Liu L,
    5. Liu G,
    6. Wang Y,
    7. Wang C,
    8. Jing J,
    9. Wang YJ
    . Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2013;22:e419–e425. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.025.
    OpenUrl
  10. 10.↵
    1. Lip GY,
    2. Nieuwlaat R,
    3. Pisters R,
    4. Lane DA,
    5. Crijns HJ
    . Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–272. doi: 10.1378/chest.09-1584.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Yoshida K,
    2. Obokata M,
    3. Kurosawa K,
    4. Sorimachi H,
    5. Kurabayashi M,
    6. Negishi K
    . Effect of sex differences on the association between stroke risk and left atrial anatomy or mechanics in patients with atrial fibrillation. Circ Cardiovasc Imaging. 2016;9:e004999. doi: 10.1161/CIRCIMAGING.116.004999.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Kim D,
    2. Shim CY,
    3. Hong GR,
    4. Kim MH,
    5. Seo J,
    6. Cho IJ,
    7. Kim YD,
    8. Chang HJ,
    9. Ha JW,
    10. Heo JH,
    11. Chung N
    . Clinical implications and determinants of left atrial mechanical dysfunction in patients with stroke. Stroke. 2016;47:1444–1451. doi: 10.1161/STROKEAHA.115.011656.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Di Tullio MR,
    2. Sacco RL,
    3. Sciacca RR,
    4. Homma S
    . Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019–2024.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med. 1998;128:639–647.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Bernhardt P,
    2. Schmidt H,
    3. Hammerstingl C,
    4. Lüderitz B,
    5. Omran H
    . Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol. 2005;45:1807–1812. doi: 10.1016/j.jacc.2004.11.071.
    OpenUrlFREE Full Text
  16. 16.↵
    1. Bhave PD,
    2. Lu X,
    3. Girotra S,
    4. Kamel H,
    5. Vaughan Sarrazin MS
    . Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015;12:1406–1412. doi: 10.1016/j.hrthm.2015.03.031.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Kassim NA,
    2. Althouse AD,
    3. Qin D,
    4. Leef G,
    5. Saba S
    . Gender differences in management and clinical outcomes of atrial fibrillation patients. J Cardiol. 2016. doi: 10.1016/j.jjcc.2016.02.022.
  18. 18.↵
    1. Hsu JC,
    2. Maddox TM,
    3. Kennedy K,
    4. Katz DF,
    5. Marzec LN,
    6. Lubitz SA,
    7. Gehi AK,
    8. Turakhia MP,
    9. Marcus GM
    . Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke. J Am Coll Cardiol. 2016;67:2913–2923. doi: 10.1016/j.jacc.2016.03.581.
    OpenUrlFREE Full Text
  19. 19.↵
    1. Shantsila E,
    2. Wolff A,
    3. Lip GY,
    4. Lane DA
    . Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. Int J Clin Pract. 2015;69:840–845. doi: 10.1111/ijcp.12625.
    OpenUrl
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation: Cardiovascular Imaging
October 2016, Volume 9, Issue 10
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Sex Effect in Atrial Fibrillation
    Arthur Labovitz and John Meriwether
    Circulation: Cardiovascular Imaging. 2016;9:e005624, originally published October 11, 2016
    https://doi.org/10.1161/CIRCIMAGING.116.005624

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation: Cardiovascular Imaging.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Sex Effect in Atrial Fibrillation
    (Your Name) has sent you a message from Circulation: Cardiovascular Imaging
    (Your Name) thought you would like to see the Circulation: Cardiovascular Imaging web site.
  • Share on Social Media
    Sex Effect in Atrial Fibrillation
    Arthur Labovitz and John Meriwether
    Circulation: Cardiovascular Imaging. 2016;9:e005624, originally published October 11, 2016
    https://doi.org/10.1161/CIRCIMAGING.116.005624
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Imaging and Diagnostic Testing
    • Echocardiography
  • Arrhythmia and Electrophysiology
    • Atrial Fibrillation
  • Stroke
    • Ischemic Stroke

Circulation: Cardiovascular Imaging

  • About Circulation: Cardiovascular Imaging
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451 
email: circ@circulationjournal.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer
  • You're the Cure

Online Communities

  • AFib Support
  • Empowered to Serve
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured